Signal transduction by a CD16/CD7/Jak2 fusion protein

Area of Science:

• Cellular signaling
• Molecular biology
• Signal transduction pathways

Background:

• Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) activate Janus protein kinase 2 (Jak2) in hormone-dependent cells.
• Understanding Jak2's role in IL-3/GM-CSF signaling is crucial for deciphering cellular responses to growth factors.

Purpose of the Study:

• To investigate the role of Jak2 in IL-3/GM-CSF-mediated signal transduction.
• To construct and express a fusion protein (CD16/Jak2) to study Jak2 activation and downstream effects.

Main Methods:

• Construction and expression of a CD16/CD7/Jak2 fusion gene using a recombinant vaccinia virus.
• Cross-linking of the fusion protein with an anti-CD16 antibody to induce activation.
• Analysis of protein phosphorylation (including Shc and pp42) and STAT protein binding via electrophoretic mobility shift assays.
• Measurement of c-fos, junB, and c-myc mRNA levels.

Main Results:

• Clustering of the CD16/Jak2 fusion protein induced its autophosphorylation but not that of endogenous Jak2 or the beta chain.
• Activated CD16/Jak2 stimulated tyrosine phosphorylation of multiple proteins (145, 97, 67, 52, 42 kDa), including Shc and mitogen-associated protein kinase (pp42).
• CD16/Jak2 activated signal transducer and activator of transcription (STAT) proteins' DNA-binding ability and increased c-fos and junB mRNA, similar to IL-3, but not c-myc.

Conclusions:

• A transmembrane CD16/Jak2 fusion protein can activate downstream signaling pathways, including protein phosphorylation and mRNA transcription.
• The signaling activated by CD16/Jak2 is similar but not identical to that induced by hematopoietic growth factors like IL-3.
• This provides a tool to study Jak2-mediated signaling independently of endogenous receptor activation.